4.7 Article

Targeting ACE2-BRD4 crosstalk in colorectal cancer and the deregulation of DNA repair and apoptosis

Related references

Note: Only part of the references are listed.
Article Cell Biology

Viral E protein neutralizes BET protein-mediated post-entry antagonism of SARS-CoV-2

Irene P. Chen et al.

Summary: Inhibitors of BET proteins, which downregulate ACE2 expression, could be potential prophylactics for SARS-CoV-2. However, it has been found that BET proteins play a critical role as antiviral factors at the post-entry level, suggesting that therapeutic inactivation of BET proteins should be avoided. BET inhibitors exacerbate SARS-CoV-2 infection, viral replication, and mortality, while suppressing interferon production.

CELL REPORTS (2022)

Article Oncology

The impact of ACE2 and co-factors on SARS-CoV-2 infection in colorectal cancer

Shuwei Li et al.

CLINICAL AND TRANSLATIONAL MEDICINE (2022)

Article Multidisciplinary Sciences

Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2

Yuanyuan Qiao et al.

Summary: Research has shown that androgens regulate the expression of ACE2, TMPRSS2, and AR in lung epithelial cells, affecting the risk of COVID-19 infection in males over 70 years old. The use of AR or BET antagonists can inhibit SARS-CoV-2 infection, providing support for further investigation into transcriptional inhibition for the treatment or prevention of COVID-19.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Oncology

High expression of ACE2 and TMPRSS2 and clinical characteristics of COVID-19 in colorectal cancer patients

Chao Liu et al.

Summary: The study found that patients with colorectal cancer have higher expression levels of ACE2 and TMPRSS2, and are more likely to exhibit clinical characteristics associated with COVID-19, indicating a potentially higher susceptibility to SARS-CoV-2 infection. Further mechanistic studies are needed to confirm these findings.

NPJ PRECISION ONCOLOGY (2021)

Article Oncology

Deacetylase Plus Bromodomain Inhibition Downregulates ERCC2 and Suppresses the Growth of Metastatic Colon Cancer Cells

Sabeeta Kapoor et al.

Summary: The study showed that epigenetic drug combinations targeting DNA repair factors could induce programmed cell death and eliminate tumors in cancer cells, with promising results in colorectal cancer patients. The examination of ERCC2 expression levels highlighted its significant role in the prognosis of colon cancer patients.

CANCERS (2021)

Review Gastroenterology & Hepatology

Epigenetics of colorectal cancer: biomarker and therapeutic potential

Gerhard Jung et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Letter Gastroenterology & Hepatology

Prolonged presence of SARS-CoV-2 viral RNA in faecal samples

Yongjian Wu et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Review Oncology

Super-enhancer function and its application in cancer targeted therapy

Faqing Tang et al.

NPJ PRECISION ONCOLOGY (2020)

Article Food Science & Technology

Heterocyclic Analogs of Sulforaphane Trigger DNA Damage and Impede DNA Repair in Colon Cancer Cells: Interplay of HATs and HDACs

Adaobi Okonkwo et al.

MOLECULAR NUTRITION & FOOD RESEARCH (2018)

Review Cell Biology

Functions of bromodomain-containing proteins and their roles in homeostasis and cancer

Takao Fujisawa et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)